Duchenne muscular dystrophy
A new multi-institution study spearheaded by researchers at Florida State University and the University of
A team of engineers at the UC Berkeley and the Keck Graduate Institute (KGI) of
Genetic edits and protein restoration in mouse models of Duchenne muscular dystrophy remain viable one
Scientists for the first time have used CRISPR gene editing to halt the progression of
A car accident leaves an aging patient with severe muscle injuries that won’t heal. Treatment
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of the
Discovery is major step towards a stem cell replacement therapy for Duchenne Muscular Dystrophy UCLA
Scientists at the University of California, Berkeley, have engineered a new way to deliver CRISPR-Cas9
Researchers from Genethon, the AFM-Téléthon laboratory, Inserm (UMR 1089, Nantes) and the University of London (Royal Holloway) demonstrated
MSI-1436 Holds Potential to Restore Heart Function After a Heart Attack Scientists at the MDI
Results From 10-Patient Case Study Lead to Phase III Clinical Trial for Patients with Duchenne
Results from a clinical trial of eteplirsen, a drug designed to treat Duchenne muscular dystrophy,
Duke University biomedical engineers have been able to repair a defect responsible for one of